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Abstract
The anatomic and histologic characteristics of the nipple-areolar complex make this breast region special. The
nipple-areolar complex can be affected by abnormal development and a wide spectrum of pathological conditions,
many of which have unspecific clinical and radiological presentations that can present a challenge for radiologists.
The nipple-areolar complex requires a specific imaging workup in which a multimodal approach is essential.
Radiologists need to know the different imaging modalities used to study the nipple-areolar complex, as well as
their advantages and limitations. It is essential to get acquainted with the acquisition technique for each modality
and the spectrum of findings for the different conditions. This review describes and illustrates a combined clinical
and radiological approach to evaluate the nipple-areolar complex, emphasizing the findings for the normal
morphology, developmental abnormalities, and the most common benign and malignant diseases that can affect
this region. We also present a diagnostic algorithm that enables a rapid, practical approach to diagnosing condition
involving the nipple-areolar complex.
Keywords: Nipple-areolar complex, Breast disease, Mammography, Sonography, Contrast-enhanced magnetic
resonance imaging
Key points
 Appropriate techniques are essential to avoid pitfalls
in the nipple-areolar complex.
 Diagnosis requires joint assessment of clinical and
multimodality imaging findings.
 Inversion differs from retraction; both occur in
benign and malignant conditions.
 Inflammatory/infectious conditions require
ultrasound follow-up study in 4 to 6 weeks.
 In case of doubt, always biopsy.
Background
The nipple-areolar complex is a region of the breast that
has unique characteristics. It is composed of different
cells and specific tissues whose main function is to facili-
tate the drainage and secretion of breast milk during lac-
tation [1]. A wide variety of abnormal conditions can
affect the nipple-areolar complex, including develop-
mental abnormalities, benign processes (e.g., inflamma-
tion, infection, tumors), and invasive and noninvasive
cancers [2–5].
Many of these conditions have nonspecific clinical and
radiological presentations that can delay diagnosis, so
evaluating the nipple-areolar complex represents a chal-
lenge for radiologists. A detailed history and clinical
examination are essential to guide the radiological man-
agement of the nipple-areolar complex. Recognizing the
different clinical signs that can manifest in the nipple-
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areolar complex (e.g., skin involvement, pathological
nipple discharge, retraction, inversion, palpable mass,
etc.) is the first step in ensuring effective radiological
management.
Imaging studies play an important role in diagnos-
ing nipple-areolar complex conditions. Since this is a
mobile, superficial region, it requires a specific ap-
proach to imaging evaluation. A meticulous radio-
logical technique is fundamental to avoid artifacts and
pitfalls. Furthermore, a multimodality approach is es-
sential. The retroareolar region is difficult to evaluate
in mammograms, so disease often goes undetected.
For this reason, other techniques such as ultrasound
(US) and even magnetic resonance imaging (MRI) are
necessary to reach the diagnosis.
Lastly, it is very important to predict tumor involve-
ment in the nipple-areolar complex before surgery.
On the one hand, knowledge of nipple-areolar com-
plex involvement is fundamental for staging disease
(prognosis); on the other hand, thanks to improve-
ments in breast-conserving techniques, it can be ex-
tremely helpful in planning the surgical management
of breast cancer [6, 7].
In this review, we use a combined clinical/multimodal
imaging approach for the nipple-areolar complex to de-
scribe and illustrate the singularities of the radiological
techniques, the normal morphology, developmental ab-
normalities, and the main benign and malignant dis-
eases. We discuss the characteristics of the different
imaging techniques and provide guidance on how to
avoid artifacts and pitfalls. Finally, we present a diagnos-
tic algorithm for a rapid, practical approach to imaging
to help ensure effective diagnosis.
Anatomy and development
Normal anatomy
The nipple-areolar complex is the pigmented area in the
most prominent part of the breast where the lactiferous
ducts draining the 15 to 20 lobes of the mammary gland
converge [8]. These lobes are oriented radially toward the
nipple, and each lobe is made up of several lobules (Fig. 1)
[1]. Each lobule has a lactiferous duct that in turn
branches and ends in the terminal ductal lobular unit
(TDLU), which is the functional unit of the breast gland
[8–10]. In the subareolar region, the ducts expand to form
Fig. 1 Anatomy of the nipple-areolar complex
Fig. 2 Morgagni tubercles. Photograph of a nipple-areolar complex.
Note the small bumps in the skin (arrow)
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Fig. 3 Milk lines. Placodes form along the milk lines, which extend from the axillae to the inguinal region (arrow)
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the lactiferous sinus [11]. The ducts then drain through 5
to 9 orifices in the nipple [10].
The nipple-areolar complex is lined with stratified ker-
atinized squamous epithelium [12]. This epithelium ex-
tends toward the inside of the orifices of the nipple
ducts, which explains how a carcinoma located in the
subareolar ducts can extend to the skin of the nipple
[12, 13]. The small raised areas on the skin of the areola
(1–2 mm) are called Morgagni tubercles (Fig. 2) [1]. The
tubercles are the openings of the ducts of the Montgom-
ery glands, modified sebaceous glands that are con-
nected to small, rudimentary mammary glands and can
therefore secrete milk [1]. These glands become more
prominent during pregnancy and help lubricate the
areola during lactation [1].
The nipple-areolar complex also contains numerous
sensory nerve endings, smooth muscle fibers, piloseba-
ceous follicles, and a rich subareolar lymphatic plexus
(Sappey plexus) [12, 13].
Embryological development
Starting in the 5th or 6th week of gestation, the ectoder-
mal ridges (also called milk lines) start to form on both
sides of the anterior aspect of the embryo, running from
the axillae to the inguinal region (Fig. 3) [11]. Placodes
forming along these ridges will later invaginate, giving rise
to several mammary buds [14, 15]. These mammary buds
normally atrophy, except the ones located in the fourth
intercostal space on either side, which will develop into the
breasts [16]. Incomplete invagination of the mammary buds
results in developmental abnormalities [2].
In the 12th through the 16th weeks of gestation,
the mesenchymal cells differentiate into smooth
muscle in the areola and nipple [9, 11]. Between the
32nd and 40th weeks, parenchymal differentiation re-
sults in the development and pigmentation of the
nipple-areolar complex [9].
Congenital anomalies
Developmental anomalies can be unilateral or bilateral
and can involve the nipple, the breast, or both [2]. These
anomalies are most common in the axillary region and
in the inframammary fold, although they can arise at any
point along the milk lines [11, 16].
The most common anomaly is polythelia, the presence
of a supernumerary nipple, which can be mistaken for a
pigmented nevus on physical examination (Fig. 4) [2].
Rarely, fibroglandular tissue underlies the accessory nip-
ple (polymastia) [9].
The congenital absence of the nipple-areolar complex
(athelia) is usually accompanied by the absence of breast
tissue (amastia) [2, 17]; more rarely, the nipple is present
but the mammary gland is absent (amazia) [2]. Under-
development of the breast is called hypoplasia [18].
Sometimes, these anomalies are found together with
other developmental anomalies and can even form part
of syndromes, such as Poland syndrome [19].
The tuberous breast deformity is a rare developmental
abnormality that is characterized by glandular hypopla-
sia, deficiency in the circumferential skin envelope at the
base of the breast, asymmetry, and herniation of fibro-
glandular tissue in the areolar region [20].
Fig. 4 Developmental abnormalities. a Photograph of polythelia in the right breast of a 45-year-old woman. b Craniocaudal and mediolateral
oblique 2D mammograms show a nodule with well-defined margins in the posterior region of the junction between the lower quadrants. c
Repeat craniocaudal mammogram with a cutaneous marker confirms that the nodule corresponds to the accessory nipple
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Imaging techniques
Due to the anatomic complexity, superficial location,
and mobility of the nipple-areolar complex, this area of
the breast requires special considerations in imaging
tests.
Mammography
For the evaluation of the retroareolar area, mammog-
raphy is less sensitive than ultrasound, partly owing to
the greater density of this complex anatomic region and
partly owing to technical difficulties due to the mobility
of this part of the breast [21, 22].
It is essential to position the breast correctly when ac-
quiring a mammogram [23–25]. It is crucial for the nip-
ple to be tangential in at least one projection, and ideally
in both the craniocaudal and mediolateral oblique pro-
jections (Fig. 5) [23]. It is often necessary to obtain
additional projections (compression or magnification) to
enable better assessment. Depending on the patient’s
body type (e.g., voluminous breasts), it might be impos-
sible to include the entire breast while maintaining the
nipple tangential. In these cases, it is helpful to obtain
an additional projection centered on the anterior region
(Fig. 6). In patients with inverted nipples (a normal vari-
ant), the nipples should be tangential and symmetrical
(Fig. 7).
To avoid pitfalls, it is important to eliminate
traces of creams or talcum powder from the skin
of the nipple (Fig. 8). Skin lesions should be
marked to avoid false-positives. Digital tomosynth-
esis can help reduce superposition artifacts and dif-
ferentiate between skin lesions and intramammary
lesions [26, 27].
Mammography is the most sensitive technique for detect-
ing calcifications [27]. In the nipple-areolar complex, calcifi-
cations are uncommon and usually benign (cutaneous,
secondary to mastoplasty, calcified intraductal detritus, calci-
fications due to fat necrosis, etc.) (Figs. 9 and 10) [28]. Micro-
calcifications can also be seen in relation to intraductal
carcinoma, sometimes associated with Paget’s disease [29].
Ultrasound
Ultrasound is very useful in the study of the nipple-
areolar complex. In addition to being widely available
and not requiring ionizing radiation, ultrasound provides
good spatial resolution of this superficial region, making
it possible to characterize small lesions in the retroareo-
lar region (especially in dense breasts). Ultrasound is
also used to guide percutaneous biopsies [22].
It is advisable to use abundant gel or even a standoff
pad to avoid air bubbles between the probe, the skin,
and the nipple that can otherwise cause a posterior
acoustic shadow [4].
It is helpful to angle the probe radially so that the
ultrasound beam hits the major axis of the duct per-
pendicularly to enable the entire length of the duct
to be seen [30]. Stavros et al. [30] described various
techniques for evaluating the nipple-areolar complex
with ultrasound (Fig. 11). Of these, peripheral com-
pression with the probe itself is the one that
achieves the best angle of incidence on the subareo-
lar ducts. The two-handed compression technique
enables better assessment of the duct at the base of
the nipple and also makes it possible to differentiate
between an intraductal mass and secretions by
checking the compressibility of the echogenic con-
tents of the duct: ducts containing debris collapse
with external compression, whereas those containing
masses do not [22, 30]. Finally, the “rolled-nipple
technique” is useful for evaluating the duct within
the nipple [22, 30].
Fig. 5 Mammography positioning. Craniocaudal and mediolateral
oblique 2D mammograms show the nipples are perfectly tangential
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Magnetic resonance imaging
Physiological uptake of contrast material in the nipple-
areolar complex can manifest in different ways (Fig. 12).
A thin symmetrical ring of enhancement is usually seen
in both breasts; sometimes enhancement is asymmetrical
in the early phase, becoming symmetrical in later phases
[31]. In a recent study of 530 normal nipples in 265
asymptomatic women, Gao et al. [32] described three
areas of enhancement in subtracted T1-weighted images
of the nipple-areolar complex acquired on a 3T scanner
and their correlation with pathology findings: (a) superfi-
cial linear enhancement (SLE); (b) nonenhancing zone
(NEZ); (c) internal nipple enhancement (INE).
The nipple is everted in 75% of women, flat in 23%,
and inverted in 2% [32]. MIP images are very useful for
assessing the morphology and symmetry of the nipple-
areolar complex. On postcontrast images, the nipple
should be hypointense or isointense to the enhanced
parenchymal tissue in the background [32].
Preoperative assessment of nipple-areolar complex
tumor involvement is essential for staging (prognosis)
and therapeutic management [33]. In the evaluation of
tumor involvement of the nipple-areolar complex, MRI
has high sensitivity (90–100%), moderate specificity (80–
90%), and a high negative-predictive value (98%) [6, 7,
34], being especially useful in cases with uncertain find-
ings on conventional imaging tests, even in the absence
of clinical suspicion [5, 35]. MRI’s usefulness derives
from its better soft-tissue resolution and the information
from dynamic contrast enhancement. Asymmetrical,
nodular, irregular, early, or persistent enhancement
should raise suspicion of malignancy (Fig. 13) [6, 28].
Moreover, as nipple-sparing mastectomy is becoming
more common for cancer treatment or for prophylaxis
in high-risk patients [36, 37], preoperative determination
of the tumor-to-nipple distance is fundamental to ensure
safety [38, 39].
Finally, MRI is also useful to complement mammog-
raphy and ultrasound in the diagnostic management of
pathological nipple discharge and to guide percutaneous
biopsy [40–44].
Galactography
Galactography is indicated in patients with pathological
discharge from the nipple (unilateral, from a single duct,
spontaneous, and persistent with a clear, serous, or
Fig. 6 Projection centered in the anterior region. A 56-year-old woman with voluminous breasts. a Craniocaudal 2D mammogram: the nipple is
not tangential and is hidden in the lower part of the breast, producing a false image of a nodule (arrow). b Repeat craniocaudal view with the
nipple tangential
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bloody appearance) and negative findings on mammog-
raphy and ultrasound [45].
To canalize the secreting orifice and inject undiluted
iodinated contrast material, the nipple must be gently
but firmly secured between the thumb and forefinger. A
30-gauge cannula is used (Fig. 14). With the cannula
fixed in place, a magnified craniocaudal projection is ob-
tained [45]. Patients may experience local pain if con-
trast material extravasates (Fig. 15) [45].
The main aim of galactography is to detect intraductal
disease and to locate the pathological duct, and this in-
formation is useful for planning surgery [46]. However,
with the development of MRI techniques, the indication
for galactography has become controversial [40, 47]. Al-
though some authors do not include galactography in
the diagnostic algorithm for the radiological manage-
ment of nipple discharge [22, 40–42], recent studies re-
affirm its usefulness, given its high sensitivity and high
negative predictive value when combined with
mammography and ultrasound (Fig. 16) [47–50]. Finally,
galactography can be used to guide interventional proce-
dures for intraductal lesions (Fig. 17) [51].
An alternative to conventional galactography is MR
galactography, which has the advantage of showing the duct
and the full extent of potential underlying disease [52].
Benign disease
Duct ectasia
First described by Haagensen [53], mammary duct ectasia
is a benign process characterized histologically by dilated
ducts, variable degrees of periductal inflammation, and
progressive fibrosis [11]. Ductal ectasia can occur at any
age, although it is most common after 50 years of age
[54]. Ectasia predominantly affects the ducts in the retro-
areolar region, bilaterally and symmetrically. Patients may
be asymptomatic (most commonly) or have nipple retrac-
tion, secretion, or a palpable subareolar nodule [28]. By
definition, the duct measures greater than 2 mm in
Fig. 7 Inverted nipples. A 60-year-old woman with inverted nipples. a Craniocaudal 2D mammograms show bilateral inverted nipples that are
perfectly tangential and symmetrical. b Photograph of the same patient
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diameter and greater than 3 mm in the ampullary portion
[8, 13]. Duct ectasia can be visible on mammograms, espe-
cially in predominantly fatty breasts. It manifests as radio-
dense tubular structures that converge in the nipple-
areolar complex (Fig. 18). The presence of benign-
appearing calcifications in the dilated subareolar ducts is a
common mammographic finding [8].
On ultrasound, duct ectasia is seen as single or mul-
tiple tubular structures that can be anechoic or have
echoes inside due to debris or infection. Ultrasound can
differentiate between debris and an intraductal mass.
Apart from compressing the duct to check to see
whether it collapses, Doppler studies can be very useful
because intraductal masses can have flow signals inside
them that indicate vascularization [8]. It is important to
remember that duct ectasia associated with an intraduc-
tal lesion or other suspicious sign should be biopsied
(Fig. 19). The ultrasound characteristics that should raise
suspicion of an underlying malignant process are periph-
erally located duct ectasia (outside the retroareolar re-
gion), diffuse irregularity of the margins of the duct,
focal wall thickening, and a hypoechoic lesion adjacent
to the duct, as well as asymmetrical duct ectasia [55, 56].
On MRI, duct ectasia is usually seen as tubular struc-
tures with a segmental distribution that have high signal
intensity on T2-weighted sequences and variable signal
intensity on T1-weighted sequences, depending on the
proteinaceous and/or hematic contents (Fig. 20) [57]. If
the ducts are not pathologic, they do not enhance after
the administration of contrast material. In some cases
with intraductal inflammation or disease, rounded,
smooth-margined ring enhancement, or even heteroge-
neous non-mass-type enhancement is seen [57].
Periductal mastitis
Periductal mastitis is a suppurative inflammatory
process that occurs mainly in non-lactating premen-
opausal women [58]. It is characterized by periductal
inflammation with an infiltrate consisting predomin-
antly of plasma cells [59]. Its etiology is uncertain,
although it could be related to bacterial infection
and obstruction of the subareolar ducts [60]. Risk
factors include smoking, obesity, and diabetes [60].
The clinical presentation consists of reddening and
pain in the areola that may be accompanied by nipple
discharge or inversion [8]. Ultrasound shows duct
ectasia with intraductal pus and increased periductal
Doppler signal (Fig. 21). On rare occasions, periductal
mastitis is associated with retroareolar abscesses,
which appear as heterogeneous ill-defined hypoechoic
masses with a posterior acoustic shadow (Fig. 22), re-
quiring a differential diagnosis with carcinoma. Thus,
the clinical context and the response to antibiotics
are key for the diagnosis. In case of doubt, clinical
and ultrasound follow-up at four to 6 weeks is rec-
ommendable [61].
Zuska’s disease
Zuska first described this recurring periareolar fistula in
1951 [62]. Zuska’s disease consists of the formation of
spontaneously draining subareolar abscesses that form
chronic periareolar fistulas [62]. It predominantly affects
non-lactating middle-aged women [63], and is directly
associated with smoking [63, 64]. It presents as a painful,
erythematous subareolar mass and recurring fistula at
the edge of the areola. Clinical suspicion is key because
the definitive treatment is surgical resection of the fistula
and the involved duct [65]. The diagnosis is clinical, but
Fig. 8 Pitfall. a Synthesized craniocaudal 2D mammogram shows
multiple dense punctiform images at the level of the nipple
mimicking calcifications; these artifacts were caused by remnants of
body cream. b Repeat image after cleansing the nipple shows the
artifacts have disappeared
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ultrasound is useful for assessing the extent of the dis-
ease (Fig. 23).
Benign tumors
The vast majority of masses located in the nipple and
subareolar region are benign.
Solitary intraductal papilloma
Although an intraductal papilloma can appear at any
age, it is most common between the third and fifth de-
cades of life, and has a low incidence in men [66, 67].
Intraductal papillomas are proliferative lesions in which
a vascular-connective axis is lined with a layer of myoe-
pithelial or basal cells and another layer of luminal epi-
thelial cells [11]. Intraductal papillomas originate in the
proximal or retroareolar ducts and generally cause ob-
struction and ectasia of the duct [68]. Intraductal papil-
loma is the most common cause of pathological nipple
discharge (48%), followed by duct ectasia (15–20%) [69].
Less frequently, this lesion can present as a palpable
mass [66].
Mammography shows a nodular or oval lesion with
well-defined margins in the retroareolar region. Up to
25% have benign calcifications [70]. Small papillomas
in the retroareolar region are often occult because of
Fig. 9 Nipple calcifications. Screening mammogram in a 54-year-old woman. a Craniocaudal view of the left breast shows a group of
calcifications in the retroareolar region (note that the nipple is not tangential). b Magnified view with the nipple perfectly tangential, confirming
that the calcifications have benign characteristics and are located in the nipple
Fig. 10 Periareolar calcifications. A 47-year-old woman with a history of breast reduction surgery. a Synthesized craniocaudal 2D mammogram
shows bilateral periareolar calcifications. b Photograph shows the periareolar scar
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the high density and technical difficulty of evaluating
this region by mammography [70]. On ultrasound,
they can be seen as an intraductal mass near the nip-
ple (with or without associated ectasia), as an intra-
cystic mass (Fig. 24), or as a predominantly solid lesion
that fills the entire duct [61]. Internal flow related to a vas-
cular pedicle may be seen on Doppler imaging (Fig. 19)
[70]. Galactography generally reveals an intraductal filling
defect (Fig. 25) or ductal cutoff (Fig. 16). On MRI, intra-
ductal papilloma can be seen as an enhancing mass with
circumscribed or irregular margins in association with
ductal dilation, as ductal dilation without an intraductal
mass, or as a solid-cystic mass [71]. Small papillomas
might not be visible on MRI.
The upgrade rate for solitary benign intraductal
papilloma (without atypia) diagnosed by core biopsy
varies widely among series (0–33% )[72], so surgical
excision has been the recommended treatment [73].
However, recent studies have shown that US-guided
directional vacuum-assisted removal with clinical and
imaging follow-up is viable [72, 74] and that cases
with good radio-pathologic concordance without asso-
ciated risk factors could even be managed with im-
aging alone [75, 76].
Nipple adenoma
Also known as florid papillomatosis, erosive adenomato-
sis, and subareolar papillomatosis, nipple adenoma is a
rare variant of intraductal papilloma [77]. It originates in
the ducts of the nipple and predominantly affects
women in the fifth decade of life [12]. Clinically, patients
may present with a small palpable nodule below the skin
of the nipple, which is typically accompanied by inflam-
matory changes in the nipple (pain, redness, and
Fig. 11 US techniques. Stavros ultrasound techniques to best demonstrate the subareolar and intranipple ducts
Fig. 12 Physiological enhancement in the nipple-areolar complex. Axial contrast-enhanced T1-weighted spoiled gradient-echo (subtracted)
images show various degrees of enhancement in a normal nipple, including none (a), mild symmetric enhancement (b), intense symmetric
enhancement (c), a thin symmetric ring of enhancement (d), and asymmetric early enhancement with symmetric late enhancement (e)
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swelling). Skin involvement results from the growth of
glandular epithelium toward the surface of the skin [12].
The cutaneous symptoms raise suspicion of Paget’s dis-
ease, so skin biopsy is usually required for histologic
study [78]. Ultrasound shows a hypoechoic nodule in
the nipple or subareolar region (Fig. 26). The treatment
is surgical; some recent publications describe cryosurgi-
cal treatment, a minimally invasive surgical technique,
for this benign condition [3].
Syringomatous tumor of the nipple
Also called infiltrating syringomatous adenoma [79], this
extremely rare benign lesion originates in the eccrine
glands of the skin of the nipple and areola [11]. Clinic-
ally, it presents as a subareolar nodule (occasionally
painful). It can cause nipple discharge or retraction.
Rarely, it is associated with ulceration and erosion of the
nipple [80]. Although benign, syringomatous adenomas
are locally invasive and often mimic a malignant lesion
on imaging tests. On mammography, it is usually seen as
an irregular hyperdense mass in the subareolar region,
although it can also present as pleomorphic calcifica-
tions in the nipple [79, 81]. Ultrasound shows an ill-
defined subareolar mass with heterogeneous echoes in-
side (Fig. 27).
The diagnosis of syringomatous adenomas is based on
the histologic appearance of the lesion and its restriction
to the dermis of the nipple [12]. Wide local excision to
ensure free margins is the optimum treatment; the rate
of recurrence is high in cases with involved margins [80,
81]. Syringomatous tumors of the nipple do not
metastasize [82].
Epidermal inclusion cyst
Also called an epidermoid cyst, this lesion is most com-
mon in the fourth decade of life [83]. This benign cuta-
neous or subcutaneous lesion arises from the
proliferation or implantation of elements from the der-
mis (keratinized squamous epithelium) in a circum-
scribed space in the dermis to form a keratin-filled cyst
[11]. Epidermal inclusion cysts can occur in any part of
the body with hair follicles, but are very uncommon in
Fig. 13 Pathological enhancement in the nipple-areolar complex. A 71-year-old woman. Axial contrast-enhanced T1-weighted spoiled gradient-echo
(subtracted) images show asymmetric irregular nodular early enhancement (a) that is maintained in late phases (b) secondary to involvement by
invasive ductal carcinoma. Irregular-shaped masslike enhancement in the middle third of the junction of the outer quadrants in the right breast with
linear uptake and segmental distribution to the nipple-areolar complex, compatible with an intraductal component (arrows)
Fig. 14 Galactography technique. 30-gauge cannula (a); the nipple must be firmly stabilized between the thumb and forefinger (b); canalization
of the discharging orifice and contrast injection (c). A magnified craniocaudal view is obtained with the cannula taped in place and the
breast compressed
del Riego et al. Insights into Imaging           (2020) 11:89 Page 11 of 27
Fig. 15: Ductograms. a Normal ductogram, craniocaudal view. Note the normal “lobular blush” in (b) (arrows), caused by the contrast material
filling the lobular portion of the terminal ductal lobular unit. Ninety-degree mediolateral ductogram (c) shows delayed extravasation from excess
injection pressure (arrow)
Fig. 16 Ductal cutoff on galactography. A 65-year-old woman with spontaneous bloody discharge from a single orifice in the right breast and
negative findings at mammography and ultrasound (images not shown). a Craniocaudal ductogram shows a concave filling defect situated 2 cm
behind the nipple. b Ultrasound obtained after galactography shows ductal ectasia with an intraductal lesion (arrow). c Sagittal T2-weighted MRI
shows hyperintense ductal ectasia with an intraductal mass, which on (d) sagittal contrast-enhanced T1-weighted MRI (subtracted image obtained 120
s after contrast injection) corresponds to a mass with differential contrast enhancement (arrow). Histologic study: solitary intraductal papilloma
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the areolar region [83]. The clinical presentation consists
of a superficial mobile nodule below the skin; on rare
occasions, they can present with nipple discharge [84].
On mammography, epidermal inclusion cysts appear
as a well-defined superficial mass or a focal asymmetry
in the retroareolar region. It is important for the mam-
mographer to mark the palpable lesion on the skin be-
fore acquiring images. Ultrasound is the technique of
choice for the diagnosis, showing an ovoid nodule with
well-defined margins that can have a solid or complex cys-
tic appearance with echogenic foci inside (related to kera-
tin); the lesion has no internal Doppler signal and variable
posterior acoustic enhancement (Fig. 28). Layered keratin
deposition is seen as the “onion-ring sign,” alternating
hyper- and hypo-echogenic concentric rings, and the
“tram-track sign,” multiple alternating hyper- and hypo-
echogenic lines [85, 86]. MRI shows a well-defined nodule
with variable low-signal intensity on T2-weighted images,
sometimes with an enhancing ring in postcontrast images
[83]. If the cyst ruptures, its appearance can be indistin-
guishable from that of a malignant lesion, requiring biopsy
specimens for histologic study [84, 87].
Complications of epidermal inclusion cysts include
rupture, inflammation, infection (abscess), and even ma-
lignant transformation into squamous-cell carcinoma
(0.045–12%, depending on the series) [83, 84]. Malignant
transformation is more common in lesions greater than
5 cm [83, 84].
Fig. 17 Galactography-guided percutaneous excision biopsy. A 59-year-old woman with a 1-week history of serous discharge from a single orifice
in her right nipple. a Ultrasound shows retroareolar ductal ectasia without apparent intraductal lesions (arrows). b Craniocaudal ductogram shows
a concave cutoff situated 2.5 cm behind the nipple. c Image of the lesion at the level of the cutoff obtained with the patient positioned prone
on the stereotactic table. d The lesion was excised with the Intact-BLES™ biopsy system (Medtronic Inc., Dublin, Ireland). Histology diagnosed
intraductal papilloma
Fig. 18 Ductal ectasia. Different examples of ductal ectasia without interior contents seen on mammography (a) and ultrasound (b, c)
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Cases with typical clinical and ultrasound findings re-
quire no treatment [83]. In these cases, biopsy is not rec-
ommended because the contents of the cyst can irritate the
surrounding tissue and increase the risk of infection [57].
Some authors recommend surgical excision of lesions
greater than 2 cm to avoid the risk of malignant transform-
ation or of lesions that cause discomfort [83, 84, 87].
Retroareolar cysts in adolescents
Retroareolar cysts in adolescents are caused by the
obstruction and dilation of the terminal ducts that
drain the Montgomery glands [88]. They can occur
unilaterally or bilaterally. There are two main clin-
ical types: inflammatory (more common) and
asymptomatic [88, 89]. The inflammatory type
Fig. 19 Ductal ectasia with intraductal contents. Solitary intraductal papilloma. A 47-year-old woman with serous secretion from a single orifice in
the right nipple. a Craniocaudal tomosynthesis slice shows a nodular image with well-defined borders in the retroareolar region of the outer
quadrants with a segmental distribution (arrows). b Ultrasound shows ductal ectasia with a well-defined solid nodular lesion (arrows) adjacent to
the nipple (N). c Doppler signal due to flow inside the intraductal lesion
Fig. 20 Ectasia and MRI. Screening MRI in an asymptomatic high-risk 38-year woman 6 months after lactation. a Unenhanced axial and sagittal
T1-weighted images. b Contrast-enhanced axial and sagittal T1-weighted MRI (subtracted image obtained 120 s after contrast injection). Note the
tubular structures in the retroareolar region of the left breast with a segmental distribution; proteinaceous material causes increased signal
intensity on T1-weighted sequences, but not intraductal enhancement
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presents as a palpable nodule associated with ery-
thema and pain. The asymptomatic type presents as
a palpable nodule without inflammatory signs or
symptoms [88]. Occasionally, these cysts are associ-
ated with serous nipple discharge.
Ultrasound is the technique of choice for both the ini-
tial assessment and follow-up. It shows one or more
fine-walled oval cystic lesions measuring less than 20
mm (Fig. 29) [88]. Inflammatory cysts can contain deb-
ris, levels or septa, and increased peripheral Doppler
signal. These cysts can be difficult to distinguish from a
retroareolar abscess, but time helps; whereas retroareolar
cysts have a benign clinical course and respond rapidly
to oral antibiotics and nonsteroidal anti-inflammatory
drugs, abscesses require drainage [89]. Symptomatic ret-
roareolar cysts should be followed up for at least 7 days
after initiating treatment to confirm the resolution of
the lesion or a decrease in size; asymptomatic cysts re-
solve spontaneously, although ultrasound follow-up is
recommended [88, 89].
Fig. 21 Periductal mastitis. Photograph of a 59-year-old smoker with a painful erythematous area in the upper outer quadrant of her right breast
(a). Ultrasound shows skin thickening and retroareolar ductal ectasia with echogenic contents (b) and increased periductal Doppler signal (c).
Fine-needle aspiration obtained purulent material (pus) (d, e)
Fig. 22 Subareolar abscess. Photograph of a 42-year-old woman with a painful erythematous palpable areolar mass in her left breast with mild
involvement of the adjacent skin (a). Synthesized 2D mammogram shows marked skin thickening of the nipple-areolar complex without other
underlying findings (b). Ultrasound shows a heterogeneous hypoechogenic intradermal collection compatible with an abscess (c). Fine-needle
aspiration was able to drain the collection completely (purulent material), and the patient was prescribed antibiotics and follow-up (d, e)
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Gynecomastia
Gynecomastia is the most common breast disease in
men [90]. It is caused by the non-neoplastic proliferation
of the mammary ducts and stroma [91]. Multiple factors
can favor gynecomastia, including physiological factors
(high estrogen concentrations in newborns, adolescents,
and the elderly), pharmacological factors, chronic disease
(e.g., cirrhosis of the liver, chronic renal failure), genetic
abnormalities (e.g., Klinefelter syndrome), hormonal dis-
turbances (e.g., hyperthyroidism), tumors (e.g., Leydig
cell tumors, Sertoli cell tumors, pituitary tumor), and
obesity [90, 92].
The clinical history, physical examination, and imaging
are important in the diagnostic workup of gynecomastia.
The condition can be unilateral or bilateral; the most
common clinical manifestation is the appearance of a
painful (or burning) palpable retroareolar mass with in-
creased breast volume [90]. Palpation reveals a soft, mo-
bile, easily depressible, concentric retroareolar mass [92].
Three mammographic patterns have been described:
nodular, dendritic, and diffuse (Fig. 30) [93, 94]. These
patterns are related to histologic changes at different
stages [90]. The nodular pattern is seen in the first year
of the development of gynecomastia, and it is related to
ductal and stromal proliferation. It is seen as a fan-
shaped retroareolar density that radiates from the nipple
that correlates with a hypoechogenic nodule with cir-
cumscribed margins on ultrasound. If the stimulus pro-
voking gynecomastia is removed, the condition is
reversible [92]. The dendritic pattern is seen more than
1 year after the onset, and it is related to fibrotic changes
in the stroma and dilation of the ducts. Mammography
Fig. 23 Zuska’s disease. a Photograph of a 47-year-old woman with a history of smoking who had a recurrent painful erythematous palpable
subareolar mass with a small secreting ulcerous lesion. b Ultrasound shows skin thickening with a small hypoechogenic collection below the
lesion (arrows), with increased peripheral color-Doppler signal (c)
Fig. 24 Solitary intraductal papilloma. A 68-year-old woman with a palpable retroareolar nodule in her left breast. a Normal findings on craniocaudal and
mediolateral oblique 2D mammograms. b Ultrasound shows a cystic lesion with a solid nodule inside it (arrow) adjacent to the nipple (N). c Hematoxylin-eosin
stain (× 4) shows branching intraductal structures consisting of a central fibrovascular axis surrounded by epithelial and myoepithelial cells
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and ultrasound both show finger-shaped prolongations
radiating from the nipple to the retroareolar region. The
diffuse pattern appears like a combination of the nodular
and dendritic patterns or similar to a heterogeneous
dense pattern in the female breast [94]. The diffuse pat-
tern is associated with exposure to external estrogens
[90]. On rare occasions, the imaging findings cannot dif-
ferentiate gynecomastia from malignancy and biopsy is
required for histologic study.
Malignant disease
Paget’s disease of the nipple
Defined by the presence of neoplastic cells (Paget cells) in
the epidermis of the nipple [4], Paget’s disease of the nipple
comprises 1% to 3% of all breast carcinomas, being most
common in the fifth and sixth decades of life [29]. This entity
is suspected clinically. It manifests with erythema, erosion,
and ulceration of the nipple, which is sometimes associated
with a palpable retroareolar mass and/or nipple retraction or
discharge (Fig. 31) [33]. The definitive diagnosis requires skin
biopsy and histologic study.
Imaging plays a fundamental role in the study of
the extent of disease and in the therapeutic manage-
ment, because 90% of cases also have an underlying
ductal carcinoma in situ or infiltrating ductal carcin-
oma [29, 33]. Mammography is the initial imaging
test. The findings include skin thickening, a retroareo-
lar mass, or pleomorphic calcifications. The mass can
Fig. 25 Intraductal filling defect. A 48-year-old woman with bloody discharge from a single orifice in the right breast and negative findings at
mammography and ultrasound (images not shown). a Craniocaudal ductogram shows a filling defect just behind the secreting orifice (arrow).
Histologic study: solitary intraductal papilloma. b Photograph of a bluish nodule that appeared in the same breast five years later; c ultrasound
shows the lesion as a solid nodule (arrow). Histologic study: solitary intraductal papilloma (inverted)
Fig. 26 Nipple adenoma. An 81-year-old woman with a several-week history of pain and swelling of the right breast. a Mammogram shows an
isodense rounded retroareolar mass with slightly irregular margins (arrows); b on ultrasound, it is seen as a solid nodular lesion (N: nipple). c
Immunohistochemistry stain with p63 (× 4) shows glandular and ductal proliferation consisting of epithelial and myoepithelial cells, which
express p63
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be seen in the subareolar region or more removed
from the nipple-areolar complex. Nevertheless, the
mammogram is normal in up to 50% of cases [28].
Ultrasound is usually done after mammography to
confirm the findings (Fig. 32). MRI is very important
for determining the extent of disease in patients with
negative mammography and ultrasound findings who
are candidates for conservative surgery (Fig. 33) [28,
29]. MRI shows abnormal uptake of contrast material,
which can be non-masslike or masslike in relation to
associated ductal carcinoma in situ or invasive ductal
carcinoma [33]. Conservative surgery has proven a vi-
able alternative to mastectomy in selected patients
with Paget’s disease [29, 95, 96].
Fig. 27 Syringomatous tumor of the nipple. A 47-year-old woman with retraction and hardening of the left nipple. a Mammogram shows retraction
of the left nipple and asymmetric retroareolar density. b On ultrasound, the lesion is solid and hypoechogenic with ill-defined borders and increased
peripheral color-Doppler signal. c Contrast-enhanced coronal T1-weighted MRI (subtracted image obtained 120 s after contrast injection) shows mass-
type uptake with pronounced early enhancement in a lesion with hazy borders that retracts the nipple-areolar complex. d Hematoxylin-eosin stain (×
4) shows a proliferation of elongated glandular structures like strings of cells in the dermis, with the formation of keratin cysts (star)
Fig. 28 Epidermal inclusion cyst. A 37-year-old woman with a palpable retroareolar nodule in her right breast, without inflammation. a Synthesized
2D mammogram (craniocaudal view) shows a well-defined isodense nodule measuring 25 mm (arrows) adjacent to the nipple. b Ultrasound shows a
well-defined hypoechogenic nodule below the skin of the right areola (N nipple)
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Ductal carcinoma in situ
Ductal carcinoma in situ is considered a precursor that
might develop into invasive cancer. By definition, it is a
noninvasive malignant cellular proliferation contained
within a duct by the basement membrane [11]. Gener-
ally, ductal carcinoma in situ is detected on screening
mammograms in asymptomatic patients; these lesions
can involve the nipple-areolar complex, in most cases by
intraductal extension.
On mammography, the most characteristic findings
are microcalcifications of variable morphology (present
in 75–90%), although it can also present as a solid mass
or even as architectural distortion [97, 98]. On ultra-
sound, ductal carcinoma in situ is usually not seen,
though it can manifest as a slightly hypoechogenic solid
mass within a duct or within the parenchyma, extending
to and dilating an adjacent duct in the retroareolar re-
gion (Fig. 34) [99]. MRI is more sensitive in the
Fig. 29 Retroareolar cyst in an adolescent. A 15-year-old girl presented with a palpable retroareolar mass in her left breast. Ultrasound shows a
large thin-walled cystic lesion (a). Follow-up ultrasound 6 months later shows a marked decrease in the size of the lesion, which is oval and
elongated (b)
Fig. 30 Radiologic patterns in gynecomastia. a Nodular. b Dendritic. c Diffuse
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detection of ductal carcinoma in situ (especially inter-
mediate- and high-grade lesions) and is more accurate
in evaluating its extent and in planning treatment [100–
102]. The most common manifestation is non-masslike
enhancement distributed segmentally or linearly with an
internal pattern of clumped enhancement [99].
Invasive ductal carcinoma
Invasive ductal carcinoma is the most common malig-
nant tumor of the breast. Occasionally, it can be located
immediately behind the nipple or it can originate in an-
other location and extend to the nipple (Fig. 35). Nearly
10% arise in the central ducts less than 2 cm from the
nipple [32].
In cases involving the nipple-areolar complex, the
most common clinical manifestation is unilateral nip-
ple retraction and distortion of the areola (Fig. 36). It
is important to differentiate between inversion and re-
traction of the nipple. Inversion refers to the
complete invagination of the nipple, which is mostly
symmetrical and physiological. Retraction refers to
focal inversion of the nipple-areolar complex and is
asymmetrical and acquired. Both inversion and retrac-
tion can have benign or malignant causes; the time
course and the presence of underlying disease are im-
portant [5].
Invasive ductal carcinoma generally presents as an ill-
defined retroareolar mass [4]. In cases of clinically sus-
pected invasive ductal carcinoma with negative findings
at mammography and ultrasound, MRI should be done.
Sometimes, the differential diagnosis must be done with
papillary lesions or retroareolar abscesses. In case of
doubt, the lesion should always be biopsied for histologic
study.
Fig. 31 Cutaneous manifestations of Paget’s disease of the nipple. a Crusted ulcerated papule in the center of the nipple. b Scaly erythematous
plaque with erosions that destroys the nipple. c Scaly erythematous plaque that covers the entire nipple
Fig. 32 Paget’s disease (I). A 56-year-old woman with right nipple retraction. a 2D mammogram shows a spiculated retroareolar mass in the right
breast with nipple retraction and skin thickening; b on ultrasound, it is seen as a solid lesion with ill-defined borders. c MRI shows the retroareolar
lesion extending to the nipple-areolar complex. Histologic study revealed infiltrating ductal carcinoma extending to the epidermis
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Fig. 33 Paget’s disease (II). An 81-year-old woman with an ulcerated lesion in her left nipple. a Synthesized 2D mammogram shows slight skin
thickening in the left nipple-areolar complex (arrows). b MRI shows differential pathologic enhancement of the left nipple-areolar complex. c, d
Hematoxylin-eosin-stained punch-biopsy specimen (× 0.3 and × 4, respectively) shows ductal carcinoma with extensive infiltration of the nipple
and ulceration of the epidermis (Paget’s disease)
Fig. 34 Ductal carcinoma in situ. a Photograph of an 85-year-old woman with a large palpable retroareolar mass with marked involvement of the right nipple-
areolar complex. b Synthesized 2D mammogram shows a circumscribed retroareolar mass with associated pleomorphic calcifications. c Ultrasound shows a
cystic mass with debris inside and a solid mural nodule with a penetrating vessel in the power-Doppler study. d Hematoxylin-eosin stain (× 10). Fragment of
the cyst wall with slight chronic inflammatory involvement and vascular congestion and epithelial lining made up of few layers of markedly pleomorphic
elements and dense eosinophilic cytoplasm. Note the proliferation of the papillary pattern, with fronds with wide fibroconnective stems lined with similar
pleomorphic elements (intraductal carcinoma within the cyst). e Close-up (Hematoxylin-eosin stain × 20)
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Fig. 35 Invasive ductal carcinoma (I). An 88-year-old woman with a palpable nodule in the lower inner quadrant of her left breast. a Synthesized
2D mammogram shows a spiculated nodule (circle), classified as infiltrating lobular carcinoma at histology. Note the thickening of the skin and of
the nipple-areolar complex (arrows). b MRI shows pathologic asymmetric enhancement of the left nipple-areolar complex. c Hematoxylin-eosin
stain of punch-biopsy specimen (× 10) shows extensive dermal infiltration by infiltrating ductal carcinoma. d Immunohistochemistry (× 4) shows
diffuse nuclear expression of estrogen receptors. These are two synchronous tumors
Fig. 36 Invasive ductal carcinoma (II). a Photograph of a 54-year-old woman with left nipple retraction. b Mammogram shows skin thickening
and increased retroareolar density; c on ultrasound, the lesion is hypoechogenic and ill-defined. d MRI shows a large lesion in the left breast
involving the nipple-areolar complex. e Hematoxylin-eosin stain (× 4) shows lymphatic invasion of the dermis of the nipple by infiltrating ductal
carcinoma (arrows)
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Radiation-associated angiosarcoma of the breast
Radiation-associated angiosarcoma of the breast is an
uncommon aggressive malignant process that develops
in women who have received radiation therapy for
previous breast cancer [103]. This condition is be-
coming more common with increased use of conser-
vative surgery, which always involves adjuvant whole-
breast radiotherapy [104]. Radiation-associated angio-
sarcoma develops 5 to 7 years after radiation therapy
and mainly affects older women. It can affect any part
of the breast, including the nipple-areolar complex
(Fig. 37) [105]. Patients present with areas of ecchym-
osis or skin thickening that mimic bruises or hemato-
mas, sometimes delaying diagnosis [105, 106].
The findings on mammography and ultrasound are
nonspecific (skin thickening, skin retraction, paren-
chymal distortion) and can even remain occult due to
changes occurring after conservative treatment. Nor-
mally, skin thickening and breast density tend to de-
crease markedly 2 years after radiation therapy. It is
very important to suspect this entity and obtain skin
biopsies in patients with skin changes and a history
of radiation therapy in the same breast [106]. MRI
shows skin thickening (seen better in T2-weighted
images) with rapid uptake in contrast-enhanced T1-
weighted imaging and pathological nipple enhance-
ment; up to 25% of cases have an associated intrapar-
enchymal mass [106, 107]. The main role of MRI is
to determine the extent of the process. Treatment
consists of wide local resection or mastectomy. The
prognosis is poor; metastases normally develop, espe-
cially in the lungs [106, 108].
Diagnostic imaging algorithm
The management of nipple disease needs to begin with a
thorough physical examination to direct the imaging
workup based on the patient’s signs and symptoms. Fig-
ure 38 shows the diagnostic imaging algorithm used at
our center.
Fig. 37 Radiation-associated angiosarcoma. A 76-year-old woman with a history of breast cancer treated with conservative surgery and whole-breast
radiation therapy 6 years prior. a Photograph shows an ill-defined erythematous-violaceous infiltrated plaque with an eroded area occupying part of
the areola. b Synthesized 2D mammogram shows skin thickening and interstitial edema in the retroareolar region of the left breast. c Ultrasound
shows an ill-defined hypoechoic skin lesion with an internal Doppler signal. Punch biopsy diagnosed radiation-associated angiosarcoma, and the
patient underwent mastectomy
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Conclusion
Imaging studies play an essential role in the diagnostic
workup of conditions involving the nipple-areolar com-
plex. The anatomic complexity of the nipple-areolar
complex requires a specific, multimodal approach to im-
aging evaluation. Radiologists must be accustomed to
meticulous management of the different imaging modal-
ities. Many conditions involving the nipple-areolar com-
plex have nonspecific clinical and radiological
presentations that can delay diagnosis. It is essential to
evaluate the clinical, radiological, and histological find-
ings together to establish an accurate diagnosis.
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